Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Jeff Vacirca Net Worth & Insider Trades

Jeff Vacirca - Director, Odonate Therapeutics, Inc

As of June 28, 2019

What is Jeff Vacirca's Net Worth?

The current estimated net worth of Odonate Therapeutics, Inc's Director, Jeff Vacirca, is estimated to be about $741.56K . Jeff Vacirca owns about 23,231 units of Odonate Therapeutics, Inc common stock. In the last 6 months at Odonate Therapeutics, Inc, Jeff Vacirca has sold an estimated value of $0 worth.

What is Jeff Vacirca's Past Insider Trading?

Jeff Vacirca's largest purchase order was 19,231 units , worth over $500.01K on June 28, 2019. In total, Jeff Vacirca has made about 3 transactions over 6 months of their time at Odonate Therapeutics, Inc. Jeff Vacirca usually trades in March, January and June, with the busiest year in 2019.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Jeff Vacirca

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Jeff Vacirca's' Mailing Address?

  • Mailing address is 4747 Executive Drive Suite 510 San Diego CA 92121 CA

What are Odonate Therapeutics, Inc's Past Insider Trades?

Odonate Therapeutics, Inc's most recent insider trade came on December 10, 2021 by Ecor Capital Llc who sold 5,887,610 units worth $9.74M . In the last 4 years, insiders at Odonate Therapeutics, Inc have sold an estimated value of $20.66M and bought an estimated value of $200M worth of shares. Insider trading is most common in December, with the busiest year in 2019. The most active traders at the company are John Lemkey, Chief Operating Officer,  Joseph Oconnell, Chief Medical Officer,  and Michael Hearne, Chief Financial Officer .

Odonate Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...